White Glove and Cold Chain Services for Advanced Healthcare Solutions #WeCare

Growth in biopharma and advanced treatments are enabling healthcare providers to take on previously untreatable diseases. This trend is resulting in better health outcomes, but also places additional demands on supply chain operations. From pre-clinical to commercial, there is a need for expanded cold chain networks, colder temperature regimes and higher service levels.

Our global cold chain network, express delivery and end-to-end monitoring capability make DHL a trusted partner to manage these changing demands. We specialize in getting your investigational medicinal product (IMP) out of the lab through to scaling to new commercial markets with precision and speed.

Discover our Capabilities

Bespoke & White Glove Services

Tailor made temperature controlled white glove services with real time tracking & same day services

Full regulatory & GxP compliance

Logistics with full regulatory compliance covering serialization, GxP requirements, customer compliance, and counterfeiting

IMP Storage & Distribution

Reliable, trusted logistics for clinical trials, with end-to-end visibility of time- and temperature-sensitive products

Warehousing & Value Added Services

Value added services such as country labelling and lot serial number tracking close to your end market

Temperature Controlled Transportation

GxP compliant Air & Ocean Freight solutions with tracking across tiered service levels to meet your requirements

Packaging & Temperature Monitoring

Active, passive & hybrid tracking and monitoring systems with packaging asset management, return, repair, repositioning & reuse

Solutions

DHL Life Sciences & Healthcare is committed to enabling you to address industry-specific challenges while driving growth and innovation, with a wide range of compliant solutions, including specialized white glove delivery with cryogenic temperature control, seamless IMP movement and end-to-end cold chain management for high-volume pharma.

Case Studies

Lighthouse Temperature-controlled Facility

Vital Signs: Symptoms of a Healthcare Sector in Transition

41%

Biopharmaceutical products will comprise 41% of the global pharmaceutical market by 2028, up from 33% in 2020.

CELL AND GENE THERAPIES

DEMAND FOR CELL AND GENE THERAPIES IS VOLATILE AND UNPREDICTABLE, BUT DELIVERY MUST BE FAST, ACCURATE AND TIGHTLY CONTROLLED.

More than 2,400

new biopharma products are currently undergoing clinical trials

END-TO-END CONTROL

MANAGING COMPLEX SUPPLY CHAINS IN A REGULATORY COMPLIANT, COST-EFFECTIVE WAY WILL DEMAND RIGOROUS END-TO-END CONTROL.

Compliant Logistics Solutions for Clinical Trials

Take a Look Inside Ocean Thermonet

Direct to X Services for Healthcare Organizations

Supply Chain Orchestration and Inventory Optimization

Supply Chain Digitalization

Sustainable Supply Chains

Take your White Glove and Cold Chain Services to the next level

Our latest report, ‘Delivering Next-Level Healthcare’ provides expert analysis on the technological, social and economic trends fuelling the current healthcare revolution. Learn all about the logistics and supply chain innovations that are now crucial to the future of healthcare.

Download Now